Zota Health Care gets registration licenses for two products in Myanmar

04 Sep 2024 Evaluate

Zota Health Care has received registration licenses for two products from the Ministry of Health Department of Food and Drug Administration, Myanmar. The company has received registration licenses for LANZOCID-30 (Each hard gelatin capsule contains: Lansoprazole USP 30mg (as enteric coated pellets) and S-AMLOZED 2.5 (Each uncoated tablet contains: S-Amlodipine Besilate eq. to S-Amlodipine 2.5mg).

The company has received said product registration licenses for the validity period of five years; further the same can be renewed after expiration. The company shall commence export of these products in Myanmar in a near term.

Zota Health Care manufactures and markets pharmaceutical formulations, nutraceutical, and ayurvedic medicines in India and internationally. 


Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×